- Pharmalittle: We’re reading about FDA drug reviews, Novartis investing $23 billion in the U.S., and more statnews.com
- Amid tariff turmoil, Swiss drugmaker commits to build $1.1B research hub in San Diego San Diego Union-Tribune
- Novartis plans to invest $23 billion in US sites as Trump renews drug tariff threats Reuters
- This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working. Barron’s
- Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D Fierce Pharma
